These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11236525)

  • 1. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). 2. Treatment].
    Konstantinow A; Mühlbauer W; Balda BR; Ring J
    Dtsch Med Wochenschr; 2001 Feb; 126(7):177-9. PubMed ID: 11236525
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.
    Paquet P; Jacob E; Damas P; Piérard GE
    Burns; 2001 Sep; 27(6):652-5. PubMed ID: 11525863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in SJS/TEN management: a brief review.
    Shokeen D
    Cutis; 2016 Mar; 97(3):E17-8. PubMed ID: 27023091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 7. [Toxic epidermal necrolysis treated with cyclosporin A].
    Carmona AF; Redondo AD; Peña LO; Gómez AG; Pareja JC; Martínez JL
    Med Intensiva; 2011 Oct; 35(7):442-5. PubMed ID: 21215491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JK; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KM; Wong GA; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    Br J Dermatol; 2016 Jun; 174(6):1194-227. PubMed ID: 27317286
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of toxic epidermal necrolysis.
    Fernando SL
    Australas J Dermatol; 2012 Aug; 53(3):165-71. PubMed ID: 22881464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis in a patient with psoriatic arthritis.
    Pace J; Adami JZ; Mallia C; Mizzi A
    Adv Exp Med Biol; 1999; 455():557-60. PubMed ID: 10599399
    [No Abstract]   [Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EuroSCAR study: cannot agree with the conclusions.
    Pehr K
    J Am Acad Dermatol; 2008 Nov; 59(5):898-9; author reply 899-900. PubMed ID: 19119105
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches.
    Singh N; Phillips M
    Skin Therapy Lett; 2022 Sep; 27(5):7-13. PubMed ID: 36469487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    Curtis JA; Christensen LC; Paine AR; Collins Brummer G; Summers EM; Cochran AL; Petersen MJ; Hull CM
    J Am Acad Dermatol; 2016 Feb; 74(2):379-80. PubMed ID: 26775781
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory Treatment of Lyell's Syndrome: A Simultaneous Plasmapheresis and Intravenous Immunoglobulins Therapy.
    Strużyna J; Surowiecka A; Korzeniowski T; Piszczek J; Korulczyk P; Drozd L; Stachura A; Torres K; Krajewski A
    J Burn Care Res; 2022 Nov; 43(6):1394-1398. PubMed ID: 35396849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study.
    Han F; Zhang J; Guo Q; Feng Y; Gao Y; Guo L; Hou Y; An J; Wang X; Yan B; Zheng Y; Song J; Li M; Wang G
    J Crit Care; 2017 Dec; 42():65-68. PubMed ID: 28688239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome in the literature and authors' own studies].
    Chłystowska M; Pietruszka-Chmarra A; Szafrański T; Michalak J
    Med Wieku Rozwoj; 2008; 12(3):799-803. PubMed ID: 19305034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Laguna C; Martín B; Torrijos A; García-Melgares ML; Febrer I
    Actas Dermosifiliogr; 2006 Apr; 97(3):177-85. PubMed ID: 16796964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of the Active Treatments for Toxic Epidermal Necrolysis.
    Kinoshita Y; Saeki H
    J Nippon Med Sch; 2017; 84(3):110-117. PubMed ID: 28724844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.